Marco Picardi

8.0k total citations
136 papers, 2.6k citations indexed

About

Marco Picardi is a scholar working on Pathology and Forensic Medicine, Oncology and Epidemiology. According to data from OpenAlex, Marco Picardi has authored 136 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pathology and Forensic Medicine, 38 papers in Oncology and 33 papers in Epidemiology. Recurrent topics in Marco Picardi's work include Lymphoma Diagnosis and Treatment (56 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Lung Cancer Treatments and Mutations (15 papers). Marco Picardi is often cited by papers focused on Lymphoma Diagnosis and Treatment (56 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Lung Cancer Treatments and Mutations (15 papers). Marco Picardi collaborates with scholars based in Italy, United States and Poland. Marco Picardi's co-authors include Bruno Rotoli, Fabrizio Pane, Amalia De Renzo, Pio Zeppa, Giancarlo Troncone, Carmine Selleri, Roberto Pacelli, Antonio Vetrani, Immacolata Cozzolino and Marco Salvatore and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marco Picardi

129 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Picardi Italy 31 810 792 622 465 425 136 2.6k
Stephen A. Geller United States 32 1.1k 1.3× 599 0.8× 1.4k 2.3× 1.1k 2.4× 258 0.6× 127 4.2k
Jean‐Luc Pellegrin France 34 691 0.9× 348 0.4× 571 0.9× 274 0.6× 1.1k 2.6× 124 4.0k
Benjamin Terrier France 45 927 1.1× 756 1.0× 309 0.5× 750 1.6× 376 0.9× 289 6.1k
Maryvonne Hourmant France 34 791 1.0× 216 0.3× 746 1.2× 1.2k 2.7× 202 0.5× 134 4.8k
Andrew E. Grulich Australia 32 1.6k 1.9× 922 1.2× 2.8k 4.5× 980 2.1× 481 1.1× 56 4.9k
William D. Boswell United States 32 282 0.3× 757 1.0× 1.2k 2.0× 882 1.9× 205 0.5× 96 3.2k
A. Hot France 35 532 0.7× 376 0.5× 255 0.4× 528 1.1× 422 1.0× 146 3.2k
Yves Chalandon Switzerland 34 728 0.9× 335 0.4× 995 1.6× 241 0.5× 321 0.8× 192 4.3k
Sanjay Thulkar India 33 446 0.6× 488 0.6× 1.0k 1.7× 1.4k 2.9× 209 0.5× 294 3.9k
Udo Kontny Germany 29 307 0.4× 331 0.4× 622 1.0× 246 0.5× 312 0.7× 96 2.5k

Countries citing papers authored by Marco Picardi

Since Specialization
Citations

This map shows the geographic impact of Marco Picardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Picardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Picardi more than expected).

Fields of papers citing papers by Marco Picardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Picardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Picardi. The network helps show where Marco Picardi may publish in the future.

Co-authorship network of co-authors of Marco Picardi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Picardi. A scholar is included among the top collaborators of Marco Picardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Picardi. Marco Picardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Picardi, Marco, Novella Pugliese, Claudia Giordano, et al.. (2025). The progression at 24 months ( POD24 ) induces a high risk of transformation of follicular lymphoma: A systematic biopsy verification. British Journal of Haematology. 208(1). 378–380.
2.
3.
4.
Pepe, Francesco, Claudia Giordano, Gianluca Russo, et al.. (2023). Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma. Cytopathology. 35(2). 182–187. 2 indexed citations
5.
6.
Iaccarino, Antonino, Pasquale Pisapia, Caterina De Luca, et al.. (2022). A roadmap for a comprehensive diagnostic approach to fine needle cytology of lymph node metastases. Cytopathology. 33(6). 668–677. 5 indexed citations
7.
8.
Vigliar, Elena, Antonino Iaccarino, Massimo Mascolo, et al.. (2021). A Novel Approach to Classification and Reporting of Lymph Node Fine-Needle Cytology: Application of the Proposed Sydney System. Diagnostics. 11(8). 1314–1314. 28 indexed citations
9.
Pugliese, Novella, Marco Picardi, Roberta Della Pepa, et al.. (2021). Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up. Cancers. 13(8). 1760–1760. 3 indexed citations
10.
Travaglino, Antonio, Claudia Giordano, Silvia Varricchio, et al.. (2020). Sjögren Syndrome in Primary Salivary Gland Lymphoma. American Journal of Clinical Pathology. 153(6). 719–724. 17 indexed citations
11.
Cerchione, Claudio, Giovanni Martinelli, Marco Picardi, et al.. (2020). Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial. Journal of Clinical Medicine. 9(2). 395–395. 6 indexed citations
12.
Aiello, Marco, Vincenzo Alfano, Elena Salvatore, et al.. (2020). [18F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging. EJNMMI Research. 10(1). 91–91. 10 indexed citations
13.
Travaglino, Antonio, Silvia Varricchio, Daniela Russo, et al.. (2020). Involvement of Helicobacter Pylori in Ocular Adnexa Lymphoma. Pathology & Oncology Research. 26(4). 2075–2081. 8 indexed citations
14.
Posteraro, Brunella, Elena De Carolis, Marianna Criscuolo, et al.. (2020). Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis. Mycoses. 63(9). 900–910. 18 indexed citations
15.
Travaglino, Antonio, Daniela Russo, Silvia Varricchio, et al.. (2020). Prognostic Significance of CD30 in Transformed Mycosis Fungoides. American Journal of Clinical Pathology. 156(3). 350–355. 6 indexed citations
16.
Travaglino, Antonio, Silvia Varricchio, Luigi Insabato, et al.. (2019). Hashimoto Thyroiditis in Primary Thyroid Non-Hodgkin Lymphoma. American Journal of Clinical Pathology. 153(2). 156–164. 37 indexed citations
17.
Picardi, Marco, Roberta Della Pepa, Claudia Giordano, et al.. (2019). Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma. Blood Advances. 3(9). 1546–1552. 17 indexed citations
18.
Travaglino, Antonio, Silvia Varricchio, Roberta Della Pepa, et al.. (2019). Prevalence of Chlamydia psittaci, Chlamydia pneumoniae, and Chlamydia trachomatis Determined by Molecular Testing in Ocular Adnexa Lymphoma Specimens. American Journal of Clinical Pathology. 153(4). 427–434. 24 indexed citations
19.
Mercurio, Valentina, Alessandra Cuomo, Roberta Della Pepa, et al.. (2019). What Is the Cardiac Impact of Chemotherapy and Subsequent Radiotherapy in Lymphoma Patients?. Antioxidants and Redox Signaling. 31(15). 1166–1174. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen A. Geller Breakdown of academic impact, for papers by Jean‐Luc Pellegrin Breakdown of academic impact, for papers by Benjamin Terrier Breakdown of academic impact, for papers by Maryvonne Hourmant Breakdown of academic impact, for papers by Andrew E. Grulich Breakdown of academic impact, for papers by William D. Boswell Breakdown of academic impact, for papers by A. Hot Breakdown of academic impact, for papers by Yves Chalandon Breakdown of academic impact, for papers by Sanjay Thulkar Breakdown of academic impact, for papers by Udo Kontny
Rankless by CCL
2026